Annular constriction of the rectum secondary to transitional cell carcinoma of the bladder

Langenstroer, Peter; Zacharias, Alex; Almagro, Urias A.; Dewire, Douglas M.

doi:10.1016/s0090-4295(99)80471-3

Cited by 18 publications

(17 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Spread to the rectum with subsequent obstruction has been reported in three cases only. The prognosis of established metastatic TCC to the rectum is universally poor with reported mean survival of 4 months [4]. To our knowledge, this is the first case of TCC involvement proximal to the rectosigmoid portion of the colon presenting with lower-GI bleeding.…”

Section: Discussionmentioning

confidence: 85%

See 1 more Smart Citation

Bladder Cancer Presenting as Lower-GI Bleeding

2008

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 85%

“…Bladder cancer rarely recurs in the GI tract [2][3][4]. Intraabdominal recurrence of bladder cancer has been attributed to potential occult metastasis and/or seeding during surgical intervention; either can explain this patient's recurrence within 5 months of his radical cystectomy and ileal conduit construction.…”

Section: Discussionmentioning

confidence: 99%

Bladder Cancer Presenting as Lower-GI Bleeding

2008

View full text Add to dashboard Cite

“…Taken together, the literature suggests that about 0.5% of all patients with MIBC will have rectal recurrence, and that this recurrence will likely be diagnosed after the patient becomes symptomatic with symptoms of bowel obstruction. 9,15,17 This signifies a large burden of morbidity in North America as 7100 patients in Canada and 70 530 in the United States were diagnosed with bladder cancer in 2010 alone. 19,20 Given that the mean survival after diagnosis of rectal recurrence of MIBC is about 5 months, an evidence-based surveillance regimen is also required to mitigate the significant mortality associated with MIBC recurrence.…”

Section: Resultsmentioning

confidence: 99%

“…10 In another study, autopsies performed on (pT2-pT4) patients with MIBC treated with cystectomy showed that 12% to 13% of patients had some form of intestinal involvement, but again data on rectal recurrence was not reported. 15,16 Most of the literature regarding rectal recurrence of muscle invasive bladder cancer comes from isolated case reports 15,17 and autopsy-based studies, which describe rectal recurrence affecting about 10% of patients with LR post-cystectomy for muscle-invasive bladder cancer. 18 Indeed this has been confirmed by a recent retrospective study using transrectal ultrasonagraphy to detect local recurrence after cystecomy, which found the rates of rectal recurrence in patients with pelvic local recurrence of bladder cancer to be as high as 9.7%.…”

Section: Discussionmentioning

confidence: 99%

A case of isolated rectal recurrence of muscle invasive bladder cancer

Kassam

Aziz

Hung

et al. 2013

CUAJ

View full text Add to dashboard Cite

We present the case of a 53-year-old man with a 25-pack/year smoking history and a 6-month history of gross hematuria, who presented with a pT3a, N0, M0, muscle invasive bladder cancer (MIBC). He declined neoadjuvant chemotherapy, but received post-cystectomy adjuvant chemotherapy. Six months post-adjuvant chemotherapy, he presented with abdominal pain and a large bowel obstruction, and was found to have an isolated rectal recurrence of MIBC. This case illustrates 2 important issues: (1) patients with a smoking history and symptoms of hematuria need to be carefully evaluated to rule out urothelial cancer; and (2) in patients with muscle invasive disease, local pelvic recurrence is common and close surveillance for recurrence needs to be implemented.

show abstract

“…Hoshi et al reported a case of intestinal perforation secondary to ileal metastasis of TCC [10]. Langenstroer et al [11] and Ito et al [12] both reported cases of bowel obstruction secondary to annular compression of the rectum. Girotra and Jani have recently reported a case of occult UGI bleeding secondary to duodenal metastasis of TCC of the urinary bladder [9].…”

Section: Discussionmentioning

confidence: 99%

Massive Upper Gastrointestinal Bleeding Secondary to Duodenal Metastasis of Transitional Cell Carcinoma of the Urinary Bladder

Chan¹,

Al-Busafi

Waschke

2011

Case Rep Gastroenterol

View full text Add to dashboard Cite

Acute upper gastrointestinal (UGI) bleeding is a common problem in our clinical practice and is often due to peptic ulcer diseases. Occasionally, malignancy may be implicated in these situations. Here we report a rare case of UGI bleeding secondary to metastatic transitional cell carcinoma (TCC) of the urinary bladder. A 62-year-old man with a history of stage IIIb TCC of the urinary bladder presented with hematemesis. Endoscopy showed a large tumor in the second stage of the duodenum that occupied 40% of the duodenal circumference, over 7 cm in length. Biopsies revealed a poorly differentiated malignant neoplasm consistent with metastasis from urothelial carcinoma that was identical to the previous surgical specimen of the urinary bladder. He was treated with supportive therapy and intravenous proton pump inhibitor and was discharged home 2 weeks later. Two weeks after discharge, the patient returned to the hospital with a painful swelling of the floor of his mouth. Biopsy again showed the same cancer type. He had unremitting bleeding from his mouth requiring multiple transfusions and a course of palliative radiation therapy. He progressively deteriorated in his cardiopulmonary and neurological functions and expired with cardiopulmonary arrest one month later.

show abstract

Annular constriction of the rectum secondary to transitional cell carcinoma of the bladder

Cited by 18 publications

References 5 publications

Bladder Cancer Presenting as Lower-GI Bleeding

Bladder Cancer Presenting as Lower-GI Bleeding

A case of isolated rectal recurrence of muscle invasive bladder cancer

Massive Upper Gastrointestinal Bleeding Secondary to Duodenal Metastasis of Transitional Cell Carcinoma of the Urinary Bladder

Contact Info

Product

Resources

About